Pan-Cancer Companies: Comp Analysis

Part
01
of one
Part
01

Pan-cancer Companies: Comp Analysis

Five companies similar to Grail are OncoCyte, 20/20 Gene Systems Inc., Nucleix, Ltd., iStat Biomedical Co., Ltd., and Exact Sciences. The five companies listed are working in pan-cancer screening for multiple cancers at the same time, through means other than DNA sequencing. We have provided details about these companies in the attached spreadsheet.

In general, all companies selected use non-invasive method for sample collection but the actual method for performing the detection varies. Details about the screening method each company profiled uses are presented in row 6 of the attached spreadsheet. OncoCyte, 20/20 Gene Systems Inc., and Exact Sciences are based in the US. Nucleix Ltd. is based in Isreal, and iStat Biomedical Ltd. is based in Taiwan.
Exact Science was primarily focused on colorectal cancer and its product. Cologuard, is FDA-approved and covered by Medicare.
In December 2017, the company bought Armune BioScience, a company that developed an immune system response technology for detecting prostate, lung, and breast cancers. Exact Science announced it intends to leverage the technology to develop tests for the ten deadliest cancers, so we profiled Exact Sciences, not Armune BioScience, in the attached spreadsheet.

CONCLUSION

To wrap up, we have completed the attached spreadsheet with a competitive analysis of companies similar to Grail as requested.
Sources
Sources